Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
---|
11/11/2010 | US20100286064 Polypeptide inhibiting transmigration of leukocytes or growth and/or metastasis of cancer cells, and fusion protein thereof |
11/11/2010 | US20100286063 GNRH agonist combination drugs |
11/11/2010 | US20100286060 Specific binding agents of human angiopoeitin-2 |
11/11/2010 | US20100286040 Pro-angiogenic peptides and uses thereof |
11/11/2010 | US20100286036 Novel peptides that enhance tight junction permeability |
11/11/2010 | US20100286035 Neuromedin u derivative |
11/11/2010 | US20100286033 New cyclic peptide compounds |
11/11/2010 | US20100286030 novel bacteriocin from a new streptomyces species |
11/11/2010 | US20100285988 Gamma-Secretase Substrates And Methods Of Use |
11/11/2010 | US20100285583 Compounds and methods for inhibiting platelet aggregation |
11/11/2010 | US20100285535 Pcr hot start by magnesium sequestration |
11/11/2010 | US20100285509 Melanoma-Associated Endogenous Retrovirus (MERV) Derived Peptide Sequences And Their Therapeutic/Diagnostic Use |
11/11/2010 | US20100285033 COMPOSITIONS AND METHODS FOR CaMKII INHIBITORS AND USES THEREOF |
11/11/2010 | US20100285025 Antibodies specific for the c-terminal regulatory domain of egfr and their use |
11/11/2010 | US20100285004 Anti-CD38 human antibodies and uses thereof |
11/11/2010 | US20100285003 Therapeutic peptides and uses thereof |
11/11/2010 | US20100284934 Diagnostic agent |
11/11/2010 | US20100284909 Immunotherapy targeting of the shared abnormal conformational state of amyloidogenic peptides/proteins |
11/11/2010 | CA2761489A1 High penetration prodrug compositions of peptides and peptide-related compounds |
11/11/2010 | CA2760064A1 Biomarker antibody and diagnosis device for detecting certain autoimmune diseases |
11/10/2010 | EP2248901A1 Streptogramines and method for preparing same by mutasynthesis |
11/10/2010 | EP2247725A1 Stat3 epitope peptides |
11/10/2010 | EP1704160B1 Methods and compositions for identifying rna-binding proteins |
11/10/2010 | EP1531836B1 Polypeptide cleavage process |
11/10/2010 | EP1381627B1 Polypeptides derived from amyloid precursor peptide (app) and their uses |
11/10/2010 | CN101883780A Human CD154-binding synthetic peptide and uses thereof |
11/10/2010 | CN101880317A Application of determination of anti-M3 receptor altered peptide antibody in diagnosis of sjogren syndrome |
11/10/2010 | CN101880316A Human RBPMS polypeptide and preparation method of antibody thereof |
11/10/2010 | CN101880315A Branch oligopeptide with analgesic activity, preparation method and application thereof |
11/09/2010 | US7829688 nucleic acid encoding peptide that inhibits the interaction of CaV2.2 with Mint1-PDZ1, a glutathione S transferase fusion protein; neurotransmitter-release angonists of CaV2.2, the pore-forming subunit of N-type of voltage-dependent calcium channels; antinocciceptive agents |
11/09/2010 | US7829665 treating hepatitis by modulating NS3/NS4 protease comprising contacting a NS3/NS4 protease with a compound of the invention |
11/09/2010 | US7829504 A solid substrate of CNT having a bonded coating of a peptide having an amino acid sequence consisting of SEQ ID Nos: 1-10; used in separation and immobilization of these structures for the fabrication of nano-devices; uniformity; purification |
11/09/2010 | US7829297 selecting therapy for a human subject having a solid epithelial tumor that overexpresses ErbB2 comprising determining whether the tumor expresses p95ErbB2; reversible dual tyrosine kinase inhibitor of both ErbB2 and epidermal growth factor receptor |
11/09/2010 | US7829064 antigen binding molecules conjugated to lipids, polymer carriers, micelles, nanoparticles or mixtures and effectors, used for therapy of diagnosis |
11/09/2010 | CA2208420C Methods and compositions for inhibition of membrane fusion-associated events, including hiv transmission |
11/04/2010 | WO2010127336A1 Modified compstatin with peptide backbone and c-terminal modifications |
11/04/2010 | WO2010124373A1 Influenza vaccine |
11/04/2010 | US20100281566 Transcriptional control element, chimeric consructs and uses therefor |
11/04/2010 | US20100280221 Peptide production and purification process |
11/04/2010 | US20100280220 Gold binding peptides and shape-and size-tunable synthesis of gold nanostructures |
11/04/2010 | US20100279950 Peptides of a melanoma antigen and their use in diagnostic, prophylactic, and therapeutic methods |
11/04/2010 | US20100279942 Methods for treating motor neuron disease |
11/04/2010 | US20100279926 Compositions and Methods for Treating Atherosclerosis |
11/04/2010 | US20100279922 Melanocortin Receptor Ligands |
11/04/2010 | US20100279918 Chimeric Constructs Between Cancer-Homing Peptides and Cell-Penetrating Peptides Coupled to Anticancer Drugs and/or Diagnostic Agent/Agents |
11/04/2010 | US20100279382 Compositions and methods for quantification of serum glycoproteins |
11/04/2010 | US20100279317 Method |
11/04/2010 | US20100278892 High affinity metal-oxide binding peptides with reversible binding |
11/04/2010 | US20100278857 Dendritic Cell Binding Proteins and Uses Thereof |
11/04/2010 | US20100278853 Constrained hiv v3 loop peptides as novel immunogens and receptor antagonists |
11/04/2010 | US20100278850 Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof |
11/04/2010 | US20100278849 Prostatic acid phosphatase antigens |
11/04/2010 | US20100278848 Tumor antigen bfy3 for prevention and/or treatment of cancer |
11/04/2010 | CA2760839A1 Modified compstatin with peptide backbone and c-terminal modifications |
11/04/2010 | CA2760392A1 Influenza vaccine |
11/03/2010 | EP2246361A1 Synthetic peptide constructs for the diagnosis and treatment of periodontitis associated with porphyromonas gingivalis |
11/03/2010 | EP2246360A1 Compositions for the treatment of gastrointestinal disorders |
11/03/2010 | EP2245043A1 A method of purifying a peptide |
11/03/2010 | CN101878023A Lung cancer-targeted peptides and applications thereof |
11/03/2010 | CN101280004B Polypeptide ERC(N5) for specific inhibition of tumor cell and tumor angiogenic blood vessel |
11/02/2010 | CA2281049C Water-soluble pharmaceutical composition in an ionic complex and the use thereof |
11/01/2010 | CA2665302A1 Cd36 modulation and uses thereof |
10/28/2010 | WO2010123519A1 Replikin-sequences for preventing/treating influenza and determining infectivity/lethality |
10/28/2010 | WO2010123013A1 Tag peptide having protease recognition sequence and utilization of same |
10/28/2010 | WO2010122245A1 Bleaching peptide hydrolysate proteasome activator and compositions containing same |
10/28/2010 | WO2010122244A1 Peptide hydrolysate proteasome activators and compositions containing same |
10/28/2010 | WO2010121835A1 Method for the manufacture of degarelix |
10/28/2010 | WO2010018378A8 Vaccine comprising amb a 1 peptides for use in the treatment of ragweed allergy |
10/28/2010 | US20100273982 Process for production of bivalirudin |
10/28/2010 | US20100273977 Process for the preparation of echinocandin derivatives |
10/28/2010 | US20100273943 Peptide conjugates and fluorescence detection methods for intracellular caspase assay |
10/28/2010 | US20100273718 Milk Protein Hydrolyzates with Reduced Immunogenic Potential |
10/28/2010 | US20100273705 Method for inhibiting "Melanoma Inhibitory Activity" MIA |
10/28/2010 | US20100273704 Methods of modulating cellular homeostatic pathways and cellular survival |
10/28/2010 | US20100273700 Use of a peptide as a therapeutic agent |
10/28/2010 | US20100273194 Immunoreactive ehrlichia p120/p140 epitopes and uses thereof |
10/28/2010 | US20100272817 Compositions and Methods for Treating Atherosclerosis |
10/28/2010 | US20100272750 Hpv polyepitope constructs and uses thereof |
10/28/2010 | US20100272739 Modulation of Gamma-Delta T Cells to Regulate Airway Hyperresponsiveness |
10/28/2010 | US20100272726 Assays, methods and means |
10/28/2010 | CA2759325A1 Replikin-sequences for preventing/treating influenza and determining infectivity/lethality |
10/28/2010 | CA2759255A1 Method for the manufacture of degarelix |
10/27/2010 | EP2243787A2 Peptides binding the phosphatase 2a protein and polynucleotides encoding same |
10/27/2010 | EP2242765A1 Short fatty acid tail polymyxin derivatives and uses thereof |
10/27/2010 | EP2242764A2 Methods and compositions related to internalizing rgd peptides |
10/27/2010 | EP2242763A1 Anti-bacterial compositions |
10/27/2010 | EP1982992B1 Hla-binding peptide, precursor thereof, dna fragment encoding the same and recombinant vector |
10/27/2010 | EP1692160B1 Fgf-5 binding and supported peptides |
10/27/2010 | EP1551762B1 Peptide derivatives, and their use for the synthesis of silicon-based composite materials |
10/27/2010 | EP1330293B2 Controlled release composition comprising lactic acid polymer, and method of producing the same |
10/27/2010 | CN101870981A Expression and purification method of heme oxygenase-1, and epitopes thereof |
10/27/2010 | CN101870974A Preparation method of proteinase activated receptors agonist and use thereof |
10/27/2010 | CN101870726A Peptide - cisplatin conjugate and preparation method and application thereof |
10/27/2010 | CN101870725A MAGE (Melanoma Antigen Gene)-4 anti-tumor CTL (Cytotoxic T Lymphocyte) epitope peptide and application thereof |
10/27/2010 | CN101870724A PLAC1 (Placenta-specific 1) anti-tumor CTL (Cytotoxic T Lymphocyte) epitope peptide and application thereof |
10/27/2010 | CN101870723A Short peptide and immunosuppressant containing the same and application thereof |
10/26/2010 | US7820784 polypeptides that stimulate the formation and cycling of pre-beta high density lipoproteins, promote lipid transport and detoxification, inhibit osteoporosis and atherosclerosis, intensify the activity anticholesterol agents, causing them to be significantly more antiinflammatory at any given dosage |
10/26/2010 | US7820671 Peptidomimetic protease inhibitors |
10/26/2010 | US7820624 which bind to human immature dendritic cells; non-viral transfection mixture comprising lipid component, polycationic nucleic acid-binding component, and peptide; gene expression inhibition; kits |
10/26/2010 | US7820621 also targeting tumor cells that express vascular endothelial growth factor neuropilin-1 receptor; radiotherapy; radiopharmaceuticals; treating angiogenesis |